0001209191-14-003192.txt : 20140114 0001209191-14-003192.hdr.sgml : 20140114 20140114200024 ACCESSION NUMBER: 0001209191-14-003192 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140110 FILED AS OF DATE: 20140114 DATE AS OF CHANGE: 20140114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolff Henry Ward CENTRAL INDEX KEY: 0001302390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 14528486 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-01-10 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001302390 Wolff Henry Ward C/O SANGAMO BIOSCIENCES INC. POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND CA 94804 0 1 0 0 Exec VP & CFO Common Stock 2014-01-10 4 M 0 10000 3.45 A 237347 D Common Stock 2014-01-10 4 S 0 10000 18.6893 D 227347 D Employee Stock Option (Right to Buy) 3.45 2014-01-10 4 M 0 10000 0.00 A 2018-12-29 Common Stock 10000 202000 D Includes 50,000 shares, 30,000 shares, and 35,000 shares subject to RSUs granted on December 8, 2011, December 6, 2012, and December 12, 2013, respectively, that will be issued as such units vest in accordance with their terms. All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2012. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.38 to $19.31, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. All shares underlying these options are vested and exercisable immediately. /s/ Florence Tam, attorney-in-fact 2014-01-14